RT @mayogastro: Interesante estudio de seroorevalencia en España. Vale la pena leerlo. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nat…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Prevalence of #SARSCOV2 in Spain #ENECOVID via @TheLancet https://t.co/42UkP4lxOB
RT @IlindelatorreMD: 5% de la población española tiene anticuerpos. https://t.co/XLSkeng2nc
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
Lancet paper on the Spanish study in full at the link below. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/B8U8iB3D56
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
This is crazy https://t.co/etKw5YDOST
#BarnardCastleEyeTest Lancet dismiss "herd immunity" as viable option: something like 20 times the current infections (and probable deaths) would be needed without a vaccine. "Barnard Castle Eye Test" #NotMovingOnTillDomIsGone not able to see report https:
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @MOUGK: High spatial variability of seroprevalence of SARS-CoV-2 in Spain. https://t.co/BNm9V4zPLs https://t.co/uVOFzAGZsP
RT @miguelmontejo74: Un estudio epidemiológico es esto. Que se publica en Lancet. El 14% de los que dieron positivo en anticuerpos ahora e…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
@gildardomd
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
Biggest serological survey yet published (61K people). Only 5% had #COVID antibodies. Rest in #Spain still susceptible, despite one of Europe’s most intense outbreaks. First nationwide population-based study https://t.co/3tU6dX0JxJ
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @SaludISCIII: "Tener anticuerpos no indica inmunidad total. Puede haber más factores de protección, pero vemos pérdida de anticuerpos de…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @Laurie_Garrett: Hotspots of #COVID19 in Spain have <10% population antibody levels. So: "In light of these findings, any proposed appro…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
"At present, herd immunity is difficult to achieve without accepting the collateral damage of many deaths in the susceptible population and overburdening of health systems." https://t.co/8UNucgavxB
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Prevalence of SARS-CoV-2 in Spain: “Most PCR-confirmed cases have detectable Ab, but a substantial proportion of people with symptoms compatible with #COVIDー19 did not have a PCR test and a third of infections determined by serology were asymptomatic”. ht
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @RaquelYotti: El estudio #ENECOVID se acaba de publicar en la prestigiosa revista @TheLancet. Una muestra del reconocimiento científico…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @IlindelatorreMD: 5% de la población española tiene anticuerpos. https://t.co/XLSkeng2nc
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @Laurie_Garrett: Hotspots of #COVID19 in Spain have <10% population antibody levels. So: "In light of these findings, any proposed appro…
RT @DrEricDing: 2) “Most PCR-confirmed cases have detectable antibodies, but a substantial proportion of people with symptoms compatible wi…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @chickenbert: Just a reminder, novel in "novel coronavirus", means it's new and we keep learning more about it. We may not reach herd i…
So herd immunity doesn't work. Public Health measures are the way forward until there is a vaccine. https://t.co/gThyMtZH3J
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Just in case anyone got the rather misleading twitter notification about covid antibodies.
RT @Rogufe: Un estudio de referencia mundial... Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiol…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @RaquelYotti: El estudio #ENECOVID se acaba de publicar en la prestigiosa revista @TheLancet. Una muestra del reconocimiento científico…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/g8ggWUGPFl, see more https://t.co/DYNr6PkPQa
RT @tsalazargr: - Sólo un 5% de los españoles tiene ya anticuerpos del covid19 - El porcentaje es mayor en el centro de la península - Un 3…
The primary article is linked here: https://t.co/aWCSDH9Yft
RT @Demostenes_eu: Parece que hay veces que hacemos las cosas bien. Un poco tarde, pero bien
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @RebuiRosa: Indispensable seguir cuidándose. Mascarilla. 2 mts de distancia. Lavarse las manos con jabón por 20 segundos. Si no tiene qu…
RT @_AlexArenas: Estamos casi en la casilla de salida. Toda precaución es poca👇